Wim Mulders

Institute of Tropical Medicine Antwerp

Belgium

Research Interests

Explore related searches

Professors in Belgium Professors in Microbiology Microbiology professors in Belgium

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Michael MARCEAU

Assistant Professor

Université de Lille

FRANCE

View details

Bouke de Jong

Head, Mycobacteriology Unit

Instituut voor Tropische Geneeskunde

BELGIUM

View details

Matthias Merker

Assistant Professor

Research Center Borstel - Leibniz Lung Center

GERMANY

View details

Claudio Köser

University of Cambridge

UNITED KINGDOM

View details

Conor Meehan

Associate Professor of Microbial Bioinformatics

University of Nottingham

UNITED KINGDOM

View details

Fabrizio Menardo

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wim Mulders

Research Interests

Explore related searches

Contact this professor

Articles (10)

Refined understanding of the impact of the <i>Mycobacterium tuberculosis</i> complex diversity on the intrinsic susceptibility to pretomanid.

Rifampicin resistance conferring mutations among <i>Mycobacterium tuberculosis</i> strains in Rwanda.

Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678.

Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

Effectiveness of GenoType MTBDR<i>sl</i> in excluding TB drug resistance in a clinical trial.

Finding the right balance between efficacy and tolerability for TB treatment: the search continues.

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region

Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant Tuberculosis.

First-line tuberculosis treatment with double-dose rifampicin is well tolerated.

The perceived impact of isoniazid resistance on outcome of first-line rifampicin-throughout regimens is largely due to missed rifampicin resistance.

Collaborators (6)

Michael MARCEAU

Bouke de Jong

Matthias Merker

Claudio Köser

Conor Meehan

Fabrizio Menardo

Make your next move.